Company
Successful launch of mivenion's Xiralite System at the European Congress of Radiology (ECR) 2009 (www.xiralite.com)
mivenion is a life-science company founded in Berlin aiming at the development and commercialization of innovative products and services for diagnosis and treatment based on optical technologies.
The evolution of light-based medical devices and novel approaches in medicinal chemistry built the basis of mivenion's product portfolio. The most distinctive feature of mivenion is its focus on product systems comprising a medical optical device and a thereupon optimized pharmaceutical product.
mivenion established a leading expertise in polymer-based drug substances and built up a versatile bioactive polymer platform.
These targeted macromolecules represent a powerful alternative to biological drug entities. The current R&D portfolio assembles development candidates in the areas of treatment of cardiovascular, neoplastic and autoimmune disorders and diagnostic imaging.
The founders of mivenion pioneered the research and development of drug substances for optical imaging and treatment. A compelling network of partners from academia and industry is supporting mivenion in achieving its goals.